Navigation Links
Understanding the functions of diversity
Date:5/21/2008

developing countries, and is also one of the topics of the exhibition. The Ecuador Research Unit has been making a significant contribution towards this issue since 2001. This Research Unit is studying both natural mountain forests and mountain forest regions that have been disturbed by human use and aims to use the findings of this comparative study to develop proposals for sustainable land use and ways of improving the living situation of the mountain people in the Andes. The Collaborative Research Centre STORMA based in Gttingen is also looking at the topic of sustainability. Its focus is on the tropical rain forests of Indonesia, which have almost halved in size over the past 50 years, primarily due to forest clearing. In cooperation with local partners, the German researchers and scientists are studying the consequences of deforestation and seeking sustainable economic strategies for the future.

The exhibition is a joint project being conducted by the Federal Ministry of Education and Research (BMBF), the DFG, the Max Planck Society, the Leibniz Association, the Helmholtz Association, Deutsche Naturwissenschaftliche Forschung e.V. (German Scientific Research Association) and Diversitas Germany.

The topic of biodiversity research is intimately connected to the Convention on Biological Diversity (CBD), an international treaty signed in Rio de Janeiro in 1992, which Germany became a party to in 1994. The goals of the treaty are to promote the conservation of biodiversity, the sustainable use of its components, and the fair and equitable sharing of benefits arising out of the utilisation of genetic resources. These goals also apply to research and are taken very seriously by the DFG when making its funding decisions. The DFG has published guidelines to assist researchers and scientists in planning research projects and funding proposals for projects relevant to the CBD.


'/>"/>

Contact: Dr. Jutta Rateike
jutta.rateike.@dfg.de
49-228-885-2665
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1 2

Related biology news :

1. Simple model cell is key to understanding cell complexity
2. AACR annual meeting showcases developments in understanding and targeting cancers
3. NYU scientists set stage for understanding how color vision is processed
4. USP Convention and Chinese Pharmacopoeia Commission sign Memorandum of Understanding
5. From delicious to death: Understanding taste
6. Scientists expand understanding of how river carbon impacts the Arctic Ocean
7. Researchers move 2 steps closer to understanding genetic underpinnings of autism
8. Atmospheric measuring device for understanding smog formation
9. Researchers discover important tool in understanding differentiation in human embryonic stem cells
10. Understanding, combating foodborne pathogens E. coli 0157 and salmonella
11. Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... Conn. , Jan. 28, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... at the upcoming RedChip Global Online CEO Conference on ... Gino Pereira , CEO of NXT-ID ... its lead product, the Wocket smart wallet and its ...
(Date:1/22/2015)... Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), ... general the State of Washington,s Department ... new enrollment and central issuance system for driver,s licenses and ... The project planning and development will start in January 2015, ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... Angelman syndrome, a neurological disorder that causes mental retardation ... has been developed by biologists at The University of ... a particular fruit fly gene, dube3a, is altered, the ... by humans whose UBE3A gene doesn,t function normally. ...
... MSG, as a flavor enhancer in their food are more likely ... even though they have the same amount of physical activity and ... Chapel Hill School of Public Health study published this month in ... China studied more than 750 Chinese men and women, aged between ...
... a deep-sea bloodhound, Sentry the newest in an ... their own in demanding and rugged environments has ... of a pioneering seafloor laboratory being planned off Washington ... a crucial step in developing an extensive sensor network ...
Cached Biology News:Model for angelman syndrome developed by University of Texas at Austin biologists 2UNC researchers find MSG use linked to obesity 2New robot scouts best locations for components of undersea lab 2New robot scouts best locations for components of undersea lab 3
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 The ... online demonstration to support life extension technologies and awareness. ... UTC, Universal Coordinated Time, on March 21st 2015, in ... world. , Eric Schulke, Founder of MILE, says, ... act with urgency. The Movement for Indefinite Life Extension ...
(Date:2/26/2015)... The Pittcon 2015 Exposition, which ... N. Morial Convention Center in New Orleans, Louisiana, ... 19, 2015) displaying products and services used by ... labs. The Exposition will offer the latest innovations ... analytical chemistry; drug discovery; nanotechnology; life sciences to ...
(Date:2/26/2015)... Feb. 26, 2015  Dyadic International, Inc. ("Dyadic") ... and proprietary technologies are used to develop, manufacture ... bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ... results for year ending December 31, 2014 after ... will host a conference call that day at ...
(Date:2/26/2015)... , Feb. 26, 2015   Lexicon Pharmaceuticals, Inc. ... management will present at the Cowen 35 th Annual ... a.m. EST in Boston .  Lexicon management ... milestones. A webcast of the presentation will be ... version of the presentation will be available at www.lexpharma.com ...
Breaking Biology Technology:Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3Pittcon 2015 Announces Exposition Highlights 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3Lexicon To Present At The Cowen 35th Annual Health Care Conference 2
... 16 IR BioSciences,Holdings, Inc. (OTC Bulletin Board: ... and CEO Michael K. Wilhelm. The purpose of ... shareholders on its subsidiary,ImmuneRegen BioSciences, past year of ... ImmuneRegen today has also filed a Form,8-K containing ...
... in the Fourth ... Quarter, ... from a 12-week, Phase 3 clinical,trial of FENTORA(R) (fentanyl buccal tablet) [C-II] ... pain,conditions. The study achieved statistical significance on the primary,endpoint. Results across the ...
... CITY, Aug. 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(TSX: ... on,endocrine therapy and oncology, today announced the filling ... the appointment of Paul Blake,M.D., as Senior Vice ... of Dr. Blake is timely and critical as ...
Cached Biology Technology:ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 2ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 3ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook 4Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 2Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 3Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 4Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 5AEterna Zentaris completes management team with the appointment of Chief Medical Officer 2AEterna Zentaris completes management team with the appointment of Chief Medical Officer 3